Radiation Oncology/Therapy

Tailoring breast radiotherapy to women's risk leads to success
By Amerigo Allegretto
Many women don't have breast cancer recurrence after receiving radiotherapy following initial treatment, a study showed at EBCC15.
March 24, 2026
Radiotherapy 400
Ablative RT doubles survival in patients with ‘supermassive’ bile duct tumors
By Will Morton
Traditionally, patients with very large tumors were not treated with high-dose ablative RT due to safety concerns.
April 2, 2026
Sample radiation treatment plan demonstrating a 'supermassive' right liver tumor with planned radiation 'isodose lines' shown in bright red and orange.
Modern EBRT reduces CVD risk in breast cancer patients
By Amerigo Allegretto
Modern EBRT for breast cancer treatment leads to minimal increases in CVD risk, an improvement over previous EBRT techniques.
April 1, 2026
Radiation Treatment Cancer Social
ASTRO: Medicare changes threaten access to cancer care
By AuntMinnie.com staff writers
More than two-thirds of physicians surveyed reporting declines of 10% or greater.
April 2, 2026
Graph Arrow Down Resized
Microbot Medical backs AMA policy on radiation protection
By AuntMinnie.com staff writers
Microbot Medical supports a new American Medical Association (AMA) policy on radiation protections for healthcare professionals.
March 5, 2026
Lead Apron 400
Mevion secures CE Mark for compact proton therapy system
By AuntMinnie.com staff writers
The S250-FIT is designed to fit into a standard radiation therapy vault, eliminating the need for purpose-built bunker construction.
February 25, 2026
Mevion
ABK Biomedical completes enrollment in IDE study
By AuntMinnie.com staff writers
The investigational device exemption (IDE) study will assess ABK Biomedical's Eye90 microspheres for hepatocellular carcinoma treatment.
February 24, 2026
Liver Cancer 400
U.S. FDA clears enhancements to Varian's Halcyon radiotherapy system
By AuntMinnie.com staff writers
The clearance includes upgrades to the system's PerfectKinetix Dynamic Couch and its Identify motion‑management capabilities.
February 23, 2026
Halcyon radiotherapy system
Radiopharmaceutical therapy use increased 20-fold over a decade
By Will Morton
Intravenous administrations of cancer therapies such as Xofigo, Lutathera, and Pluvicto have increased by more than 2000%.
February 19, 2026
Graph Financial Results Tablet 400
Pooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPC
By Will Morton
Lu-177 PSMA-617 has a 36% relative reduction in risk of progression versus standard therapies.
February 18, 2026
Prostate Imaging
UNC Health to install Mevion’s proton therapy system
By AuntMinnie.com staff writers
UNC Health will install Mevion's S250-FIT after converting a treatment room to support proton therapy in its established oncology ecosystem.
February 17, 2026
Radiation Treatment Cancer 400
Study questions routine use of radiotherapy after bone surgery
By Will Morton
Findings suggest a possible hazard associated with postoperative radiotherapy.
February 13, 2026
2026 02 13 Port Fractures Thumbnail
Page 1 of 469
Next Page